S-Biomedic

S-Biomedic

A skin microbiome research company, developing pro and post-biotic ingredients from true skin commensals. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
EBITDA(<1m)(<1m)(<1m)(<1m)<1m(4.3m)-
Profit(<1m)(<1m)(1.1m)(1.1m)(<1m)(6.1m)<1m
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

€2.0m

Series A

N/A

Early VC

€1.3m

Grant

N/A

Early VC
*

N/A

Acquisition
Total Funding€5.3m

Recent News about S-Biomedic

Edit
More about S-Biomedic
Edit

Developer of novel therapeutics intended to establish methods to directly modulate the skin microbiome. The company's products are made by selecting beneficial bacteria that accelerate the rebalancing of a diseased microbiome and help to restore healthy skin, enabling clinicians to treat acne, eczema, rosacea, and aging.

Keywords: Pharmaceuticals and Biotechnology,

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.